Hellow guys, Welcome to my website, and you are watching The genomics of Waldenström’s macroglobulinemia and what this tells us about its curability. and this vIdeo is uploaded by VJHemOnc – Video Journal of Hematology & HemOnc at 2022-10-29T07:34:48-07:00. We are pramote this video only for entertainment and educational perpose only. So, I hop you like our website.
| Name | The genomics of Waldenström’s macroglobulinemia and what this tells us about its curability |
| Video Uploader | Video From VJHemOnc – Video Journal of Hematology & HemOnc |
| Upload Date | This Video Uploaded At 29-10-2022 14:34:48 |
| Video Discription | Steven Treon, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, gives an overview of the genomics of Waldenström’s macroglobulinemia (WM), and highlights the importance of using novel therapeutic agents to target CXCR4 and MYD88 mutations. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved. |
| Category | Education |
| Tags | Speaker: Steven Treon | Institution: Dana-Farber Cancer Institute | Event: IWWM-11 2022 | Format: Interview | Subject: Lymphoma | Subject: Non-Hodgkin Lymphoma | Subject: Rare Diseases | Subject: Waldenström’s macroglobulinemia | Field: Disease biology | Field: Treatment | CXCR4 | MYD88 |
